Mental Health Blogs

News is out that the federal Department of Justice is investigating Abbott Labs over questions about its marketing of Depakote, its anti-seizure drug that’s also approved for bipolar disorder. It’s not clear what the scope of the investigation is, so stay tuned.

Go to Source

Related posts:

1. AstraZeneca To Pay Feds $520 Million To Settle Seroquel Claims
2. FDA Issues Major Birth Defects Warning For Depakote
3. Utah Settles Zyprexa Claims For $24 Million
4. FDA Staff Urge Review Of Developmental Delay, Autism Linked To Depakote
5. Study Touts Depakote For ADHD Kids Who Are Disruptive